These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26911032)

  • 1. [Prevention and handling of missing data in clinical trials].
    Jiang ZW; Li CJ; Wang L; Xia JL
    Yao Xue Xue Bao; 2015 Nov; 50(11):1402-7. PubMed ID: 26911032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of missing data and how it is handled on the rate of false-positive results in drug development.
    Barnes SA; Mallinckrodt CH; Lindborg SR; Carter MK
    Pharm Stat; 2008; 7(3):215-25. PubMed ID: 17853425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
    Lane P
    Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
    Olsen IC; Kvien TK; Uhlig T
    Osteoarthritis Cartilage; 2012 Aug; 20(8):822-8. PubMed ID: 22441031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.
    Mallinckrodt CH; Sanger TM; Dubé S; DeBrota DJ; Molenberghs G; Carroll RJ; Potter WZ; Tollefson GD
    Biol Psychiatry; 2003 Apr; 53(8):754-60. PubMed ID: 12706959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fallacies of last observation carried forward analyses.
    Lachin JM
    Clin Trials; 2016 Apr; 13(2):161-8. PubMed ID: 26400875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple imputation: dealing with missing data.
    de Goeij MC; van Diepen M; Jager KJ; Tripepi G; Zoccali C; Dekker FW
    Nephrol Dial Transplant; 2013 Oct; 28(10):2415-20. PubMed ID: 23729490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of multiple imputation methods for handling missing values in longitudinal data in the presence of a time-varying covariate with a non-linear association with time: a simulation study.
    De Silva AP; Moreno-Betancur M; De Livera AM; Lee KJ; Simpson JA
    BMC Med Res Methodol; 2017 Jul; 17(1):114. PubMed ID: 28743256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Move over LOCF: principled methods for handling missing data in sleep disorder trials.
    Olsen MK; Stechuchak KM; Edinger JD; Ulmer CS; Woolson RF
    Sleep Med; 2012 Feb; 13(2):123-32. PubMed ID: 22172964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Practice in Japan for the Prevention and Treatment of Missing Data in Confirmatory Clinical Trials: A Survey of Japanese and Foreign Pharmaceutical Manufacturers.
    Tanaka S; Fukinbara S; Tsuchiya S; Suganami H; Ito YM
    Ther Innov Regul Sci; 2014 Nov; 48(6):717-723. PubMed ID: 30227476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: a simulation study.
    Baron G; Ravaud P; Samson A; Giraudeau B
    Arthritis Rheum; 2008 Jan; 59(1):25-31. PubMed ID: 18163406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the practical application of mixed effects models for repeated measures to clinical trial data.
    Andersen SW; Millen BA
    Pharm Stat; 2013; 12(1):7-16. PubMed ID: 23239585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.
    Jørgensen AW; Lundstrøm LH; Wetterslev J; Astrup A; Gøtzsche PC
    PLoS One; 2014; 9(11):e111964. PubMed ID: 25409438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.